ABSTRACT
CMI..............................................................................................335 24.2.1 HIV Disease Management: Monitoring Pathogenesis .........................................335 24.2.2 Monitoring Efficacy of Therapy...........................................................................336 24.2.3 Immune Reconstitution.........................................................................................337 24.2.4 Response to Vaccination.......................................................................................337 24.2.5 Immune-Based Therapy: Screening Assays.........................................................338 24.2.6 Hepatitis C Virus ..................................................................................................339 24.2.7 Organ Transplantation ..........................................................................................340 24.2.8 Cancer ...................................................................................................................340 24.2.9 Autoimmunity .......................................................................................................341 24.2.10 Vaccine Development ...........................................................................................341 24.2.11 Biopharmaceutical Development..........................................................................342
